Skip to main content

Table 2 History of PID

From: Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort “Visages”

  N = 116   
Age at PID diagnosis (years)   31.6 ± 20.3 [0–79.6; 32.4]
Time from PID diagnosis (years)   10.2 ± 9.9 [0.4–50.6; 6.6]
Type of PID    
• Agammaglobulinemia 1 0.9 %  
• X-linked agammaglobulinemia 5 4.3 %  
• Hypogammaglobulinemia 9 7.8 %  
• Common variable immune deficiency 76 65.5 %  
• Severe combined immuno-deficiency 4 3.5 %  
• IgG subclass deficiency with recurrent infections 12 10.3 %  
• Other PID 9 7.8 %  
At least one severe infection within the previous 12 months 6 5.2 %